This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
4 Entwicklung neuer Medikamente
Allen TM, Martin FJ (2004) Advantages of liposomal delivery systems for anthracyclines. Semin Oncol 31(Suppl 13): 5–15
Basso LA, Pereira da Silva LH, Fett-Neto AG, Filguera de Azevedo W jun, de Souza Moreira I, Palma MS, Calixto JB, Astolfi Filho S, Ribeiro dosSantos R, Pereira Soares MB, Santiago Santos D (2005) The use of biodiversity as source of new chemical entities against defined molecular targets for treatment of malaria, tuberculosis, and T-cell mediated diseases — A review. Mem Inst Oswaldo Cruz 100: 575–606
Bredel M, Jacoby E (2004) Chemogenomics: an emerging strategy for rapid target and drug discovery. Nature Rev 5: 262–275
Egner U, Krätzschmar J, Kreft B, Pohlenz HD, Schneider M (2005) The target discovery process. ChemBioChem 6: 468–479
Fradera X, Mestres J (2004) Guided docking approaches to structure-based design and screening. Curr Topics Med Chem 4: 687–700
Johnson-Leger C, Power CA, Shomade G, Shaw JP, El Proudfoot A (2006) Protein therapeutics — lessons learned and a view of the future. Expert Opin Biol Ther 6: 1–7
Kidane A, Bhatt PP (2005) Recent advances in small molecule drug delivery. Curr Opin Biotechnol 9: 347–351
Lazo JS, Wipf P (2000) combinatorial chemistry and contemporary pharmacology. J Pharmacol Exp Ther 293: 705–709
Lister T. Combinatorial chemistry — the future for drug discovery? http://www.chemsoc.org/pdf/LearnNet/rsc/Atmos.pdf (Recherchedatum: 16.01.2006)
Loregian A, Palu G (2005) Disruption of protein-protein interactions: towards new targets for chemotherapy. J Cell Physiol 204: 750–762
Moghimi SM, Hunter AC, Murray JC (2005) Nanomedicine: current status and future prospects. FASEB J 19: 311–330
Newman DJ, Cragg GM, Snader KM (2003) Natural Products as Sources of New Drugs over the Period 1981–2002, J Nat Prod 66: 1022–1037
Park JW, Benz CC, Martin FJ (2004) Future directions of liposome-and immunoliposome-based cancertherapeutics. Semin Oncol 31(Suppl 13): 196–205
Weber L (2005) Current status of virtual combinatorial library design. QSAR Comb Sci 24: 809–823
Rights and permissions
Copyright information
© 2006 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
(2006). Entwicklung neuer Medikamente. In: Molekulare Pharmakologie und Toxikologie. Springer-Lehrbuch. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-48245-1_4
Download citation
DOI: https://doi.org/10.1007/978-3-540-48245-1_4
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-21223-2
Online ISBN: 978-3-540-48245-1
eBook Packages: Life Science and Basic Disciplines (German Language)